Thioredoxin redox signaling in the ischemic heart: An insight with transgenic mice overexpressing Trx1

Journal of Molecular and Cellular Cardiology

Volumn 35, Issue 6, 2003, Pages 695-704

  Turoczi, Tibor ^a,b   Chang, Vincent Wen Hsing ^a,b   Engelman, Richard M ^a,b   Maulik, Nilanjana ^a,b   Ho, Ye Shih ^a,b   Das, Dipak K ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Adapted heart; Ischemia reperfusion; Redox signaling; Thioredoxin; Trx1 transgenic mouse

Indexed keywords

CISPLATIN; REACTIVE OXYGEN METABOLITE; THIOREDOXIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISOLATED HEART; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

MAMMALIA; MUS MUSCULUS;

EID: 0038279860     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2828(03)00117-2     Document Type: Article

References (41)

1. Arscott L.D., Gromer S., Schirmer R.H., Becker K., Williams C.H. Jr. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA. 94:1997;3621-3626.
2. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem. 264:1989;13963-13966.
3. Holmgren A., Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry. 17:1978;4071-4077.
4. Prieto-alamo M.J., Jurado J., Gallardo-madueno R., Monje-casas F., Holmgren A., Pueyo C. Transcriptional regulation of glutaredoxin and thioredoxin pathways and related enzymes in response to oxidative stress. J Biol Chem. 275:2000;13398-13405.
5. Tanaka T., Nishiyama Y., Okada K., Hirota K., Matsui M., Yodoi J., et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest. 77:1997;145-155.
6. Das D.K. Redox regulation of cardiomyocyte survival and death. Antioxid Redox Signal. 3:2001;23-37.
7. Das D.K., Engelman R.M., Maulik N. Oxygen free radical signaling in ischemic preconditioning. Annals NY Acad Sci. 874:1999;49-68.
8. Maulik N., Sasaki H., Addya S., Das D.K. Regulation of cardiomyocyte apoptosis by redox-sensitive transcription factors. FEBS Lett. 485:2000;7-12.
9. Maulik N., Sato M., Price B.D., Das D.K. An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429:1998;365-369.
10. Yagi K., Liu C., Bando T., Yokomise H., Inui K., Hitomi S., et al. Inhibition of reperfusion injury by human thioredoxin (adult T-cell leukemia-derived factor) in canine lung transplantation. J Thoracic Cardiovasc Surg. 108:1994;913-921.
11. Nakamura H., Vaage J., Valen G., Padilla C.A., Bjornstedt M., Holmgren A. Measurements of plasma glutaredoxin and thioredoxin in healthy volunteers and during open-heart surgery. Free Rad Biol M. 24:1998;1176-1186.
12. Kihlstrom M. Protection effect of endurance training against reoxygenation-induced injuries in rat heart. J Appl Physiol. 68:1990;1672-1678.
13. Isowa N., Yoshimura T., Kosaka S., Liu M., Hhitomi S., Yodoi J., et al. Human thioredoxin attenuates hypoxia/reoxygenation injury of murine endothelial cells in a thiol-free condition. J Cell Physiol. 182:2000;33-40.
14. Gunning P., Leavitt J., Muscat G., Ng S.Y., Kedes L. A human β-actin expression vector system directs high-level accumulation of anti-sense transcripts. Proc Natl Acad Sci USA. 84:1987;4831-4835.
15. Hogan B., Beddington R., Constantini F., Lacey E. Manipulating the mouse embryo: a laboratory manual. 1994;Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
16. Chirgwin J.M., Przybyla A.E., Macdonald R.J., Rutter W.J. Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry. 18:1979;5294-5299.
17. Thomas P.S. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA. 77:1980;5201-5205.
18. Engelman D.T., Watanabe M., Engelman R.M., Rousou J.A., Kisin E., Kagan V.E., et al. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res. 29:1995;133-140.
19. Ray P.S., Martin J.L., Swanson E.A., Otani H., Dillmann W.H., Das D.K. Transgene overexpression of alpha B crystallin confers simultaneous protection against cardiomyocyte apoptosis and necrosis during myocardial ischemia and reperfusion. FASEB J. 15:2001;393-402.
20. Sato M., Cordis G.A., Maulik N., Das D.K. SAPKs regulation of ischemic preconditioning. Am J Physiol. 279:2000;H901-H907.
21. Imamura G., Bertelli A.A., Bertelli A., Otani H., Maulik N., Das D.K. Pharmacological preconditioning with resveratrol: an insight with iNOS knockout mice. Am J Physiol. 282:2002;H1996-H2003.
22. Hattori R., Maulik N., Otani H., Zhu L., Cordis G., Engelman R.M., et al. Role of Stat 3 in ischemic preconditioning. J Mol Cell Cardiol. 33:2001;1929-1936.
23. Cordis G.A., Maulik N., Das D.K. Detection of oxidative stress in heart by estimating the dinitrophenylhydrazine derivative of malonaldehyde. J Mol Cell Cardiol. 27:1995;1645-1653.
24. Ho Y-S., Vincent R., Dey M.S., Slot J.W., Crapo J.D. Transgenic models for the study of lung antioxidant defense: enhanced manganese-containing superoxide dismutase activity gives partial protection to B6C3 hybrid mice exposed to hyperoxia. Am J Resp Cell Mol Biol. 18:1998;538-547.
25. Arner E.S.J., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 267:2000;6102-6109.
26. Maulik N., Das D.K. Redox signaling in vascular angiogenesis. Free Rad Biol M. 33:2002;1047-1060.
27. Maulik N., Goswami S., Galang N., Das D.K. Differential regulation of Bcl-2, AP-1 and NFκB on cardiomyocyte apoptosis during myocardial ischemic stress adaptation. FEBS Lett. 443:1999;331-336.
28. Das D.K., Maulik N., Sato M., Ray P.S. Reactive oxygen species function as second messengers during preconditioning of heart. Mol Cell Biochem. 196:1999;59-67.
29. Maulik N., Yoshida T., Engelman R.M., Deaton D., Flack J.E. III, Rousou J.A., et al. Ischemic preconditioning attenuates apoptotic cell death associated with ischemia/reperfusion. Mol Cell Biochem. 186:1998;139-145.
30. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17:1998;2596-2606.
31. Schenk H., Klein M., Erlbrugger W., Droge W., Schulze-osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFκB and AP-1. Proc Natl Acad Sci USA. 91:1994;1672-1676.
32. Chandrasekar B., Smith J.B., Freeman G.L. Ischemia-reperfusion of rat myocardium activates nuclear factor-kappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation. 103:2001;2296-2302.
33. Maulik N., Das D.K. Potentiation of angiogenic response by ischemic and hypoxic preconditioning of the heart. J Cell Mol M. 6:2002;13-24.
34. Valen G., Yan Z.Q., Hansson G.K. Nuclear factor kappa-B and the heart. J Am Coll Cardiol. 38:2001;307-314.
35. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol. 15:1997;351-369.
36. Das K.C., Lewis-Molock Y., White C.W. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol. 17:1997;713-726.
37. Das D.K., Moraru I.I., Maulik N. Gene expression in acute myocardial stress. J Mol Cell Cardiol. 27:1995;181-193.
38. Das D.K., Engelman R.M., Kimura Y. Molecular adaptation of cellular defenses following preconditioning of the heart by repeated ischemia. Cardiovasc Res. 27:1993;578-584.
39. Holmgren, Bj^rnstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol. 252:1995;199-208.
40. Chen Z., Siu B., Ho Y-S., Vincent R., Chua C.C., Hamdy R.C., et al. Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J Mol Cell Cardiol. 30:1998;2281-2289.
41. Kishimoto C., Shioji K., Nakamura H., Nakayama Y., Yodoi J., Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J. 65:2001;491-494.